Annual SG&A
$11.96 M
+$4.69 M+64.52%
31 December 2023
Summary:
Ocuphire Pharma annual selling, general & administrative expenses is currently $11.96 million, with the most recent change of +$4.69 million (+64.52%) on 31 December 2023. During the last 3 years, it has risen by +$9.14 million (+324.38%). OCUP annual SG&A is now at all-time high.OCUP Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$2.89 M
-$460.00 K-13.71%
30 September 2024
Summary:
Ocuphire Pharma quarterly selling, general & administrative expenses is currently $2.89 million, with the most recent change of -$460.00 thousand (-13.71%) on 30 September 2024. Over the past year, it has increased by +$839.00 thousand (+40.83%). OCUP quarterly SG&A is now -38.03% below its all-time high of $4.67 million, reached on 31 March 2024.OCUP Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$370.24 M
-$27.19 M-7.93%
30 September 2024
Summary:
Ocuphire Pharma TTM selling, general & administrative expenses is currently -$370.24 million, with the most recent change of -$27.19 million (-7.93%) on 30 September 2024. Over the past year, it has dropped by -$380.97 million (-3549.21%). OCUP TTM SG&A is now -1033.09% below its all-time high of $14.34 million, reached on 31 March 2024.OCUP TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
OCUP Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +64.5% | +40.8% | -3549.2% |
| 3 y3 years | +324.4% | +81.4% | -4718.2% |
| 5 y5 years | - | - | - |
OCUP Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +324.4% | -38.0% | +104.7% | -39.1% | +5.5% |
| 5 y | 5 years | at high | +557.1% | -38.0% | +640.1% | -1033.1% | +5.5% |
| alltime | all time | at high | +557.1% | -38.0% | +640.1% | -1033.1% | +5.5% |
Ocuphire Pharma Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $2.89 M(-13.7%) | $14.20 M(+6.3%) |
| June 2024 | - | $3.35 M(-28.2%) | $13.36 M(-6.9%) |
| Mar 2024 | - | $4.67 M(+42.4%) | $14.34 M(+19.9%) |
| Dec 2023 | $11.96 M(+64.5%) | $3.28 M(+59.6%) | $11.96 M(+11.4%) |
| Sept 2023 | - | $2.06 M(-52.6%) | $10.73 M(+3.4%) |
| June 2023 | - | $4.34 M(+89.9%) | $10.38 M(+32.8%) |
| Mar 2023 | - | $2.29 M(+11.2%) | $7.82 M(+7.6%) |
| Dec 2022 | $7.27 M | $2.05 M(+20.6%) | $7.27 M(+9.7%) |
| Sept 2022 | - | $1.70 M(-4.1%) | $6.63 M(+1.7%) |
| June 2022 | - | $1.78 M(+2.3%) | $6.52 M(-20.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $1.74 M(+22.8%) | $8.15 M(+0.4%) |
| Dec 2021 | $8.12 M(+188.2%) | $1.41 M(-11.3%) | $8.12 M(+1.3%) |
| Sept 2021 | - | $1.59 M(-53.2%) | $8.02 M(+14.7%) |
| June 2021 | - | $3.41 M(+100.0%) | $6.99 M(+69.2%) |
| Mar 2021 | - | $1.70 M(+30.1%) | $4.13 M(+46.6%) |
| Dec 2020 | $2.82 M(+54.8%) | $1.31 M(+131.9%) | $2.82 M(+86.9%) |
| Sept 2020 | - | $565.00 K(+2.5%) | $1.51 M(+60.0%) |
| June 2020 | - | $551.00 K(+40.9%) | $942.00 K(+140.9%) |
| Mar 2020 | - | $391.00 K | $391.00 K |
| Dec 2019 | $1.82 M | - | - |
FAQ
- What is Ocuphire Pharma annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Ocuphire Pharma?
- What is Ocuphire Pharma annual SG&A year-on-year change?
- What is Ocuphire Pharma quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Ocuphire Pharma?
- What is Ocuphire Pharma quarterly SG&A year-on-year change?
- What is Ocuphire Pharma TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Ocuphire Pharma?
- What is Ocuphire Pharma TTM SG&A year-on-year change?
What is Ocuphire Pharma annual selling, general & administrative expenses?
The current annual SG&A of OCUP is $11.96 M
What is the all time high annual SG&A for Ocuphire Pharma?
Ocuphire Pharma all-time high annual selling, general & administrative expenses is $11.96 M
What is Ocuphire Pharma annual SG&A year-on-year change?
Over the past year, OCUP annual selling, general & administrative expenses has changed by +$4.69 M (+64.52%)
What is Ocuphire Pharma quarterly selling, general & administrative expenses?
The current quarterly SG&A of OCUP is $2.89 M
What is the all time high quarterly SG&A for Ocuphire Pharma?
Ocuphire Pharma all-time high quarterly selling, general & administrative expenses is $4.67 M
What is Ocuphire Pharma quarterly SG&A year-on-year change?
Over the past year, OCUP quarterly selling, general & administrative expenses has changed by +$839.00 K (+40.83%)
What is Ocuphire Pharma TTM selling, general & administrative expenses?
The current TTM SG&A of OCUP is -$370.24 M
What is the all time high TTM SG&A for Ocuphire Pharma?
Ocuphire Pharma all-time high TTM selling, general & administrative expenses is $14.34 M
What is Ocuphire Pharma TTM SG&A year-on-year change?
Over the past year, OCUP TTM selling, general & administrative expenses has changed by -$380.97 M (-3549.21%)